Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 10/20 | 0.59 |
| ▸ | HTR2A | P28223 | 6/20 | 0.47 |
| ▸ | HTR1D | P28221 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 2/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12311975 | 0.83 | TAAR1 (0.64) | TAAR1HTR2AHTR1DCYP1A2CYP2A6 | |
| SCHEMBL21032335 | 0.83 | CYP1A2 (0.41) | TAAR1HTR2ACYP1A2CYP2A6HTR2C | |
| SCHEMBL4930876 | 0.83 | HTR2A (0.43) | TAAR1HTR2AHTR1DCYP1A2CYP2A6 | |
| SCHEMBL10817318 | 0.82 | AMY1A (0.42) | TAAR1HTR2ACYP1A2CYP2A6HTR2C | |
| Hydrochloric Acid SCHEMBL2795521 | 0.82 | TAAR1 (0.62) | TAAR1HTR2AHTR1DCYP1A2CYP2A6 | |
| SCHEMBL16958419 | 0.81 | L3MBTL1 (0.38) | TAAR1HTR2ACYP1A2CYP2A6HTR2C | |
| SCHEMBL29280309 | 0.79 | TAAR1 (0.35) | TAAR1HTR2ACYP1A2HTR2CHTR2B | |
| SCHEMBL17429675 | 0.79 | SMN1; SMN2 (0.37) | TAAR1HTR2ACYP1A2HTR2CHTR2B | |
| SCHEMBL855681 | 0.78 | TAAR1 (0.69) | TAAR1HTR2AHTR1DCYP1A2CYP2A6 | |
| SCHEMBL30251350 | 0.78 | TAAR1 (0.69) | TAAR1HTR2AHTR1DCYP1A2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006060654-A2 | PESTICIDAL COMPOSITIONS AND METHODS | DIVERGENCE, INC. (US) | 2006-06-08 | — | — | WO | claimed |
| US-20050203067-A1 | Pesticidal compositions and methods | DIVERGENCE, INC. | 2005-09-15 | — | — | US | claimed |
| WO-2006060654-A2 | PESTICIDAL COMPOSITIONS AND METHODS | DIVERGENCE, INC. (US) | 2006-06-08 | — | — | WO | disclosed |
| US-20050203067-A1 | Pesticidal compositions and methods | DIVERGENCE, INC. | 2005-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203067-A1 | Pesticidal compositions and methods | ACHE, DDT, PTMS | TAAR1 2664/4885HTR2A 2898/4885HTR1D 3500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.